Stay updated on Pembrolizumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page shows Revision: v3.4.2; the earlier funding-status notice (Revision: v3.4.1) has been removed.
    Difference
    0.4%
    Check dated 2026-02-11T02:20:01.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Additions include a site-wide funding/operational status notice (NIH Clinical Center is open) and a new Revision: v3.4.1; a prior Revision: v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:44:50.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added UI/text elements: 'Show glossary', 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a new revision label 'Revision: v3.4.0'. Removed or renamed older labels: 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-27T23:46:23.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 in the Study Documents section. This appears to be a metadata/version update to the protocol/document rather than a change to trial design or results; to avoid alerts for small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-13T17:56:12.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a Locations section listing Washington as a study site (Seattle, WA) and removed the prior Washington Locations label and the HHS Vulnerability Disclosure link; page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:33:46.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The header now displays Revision: v3.3.2, replacing Revision: v3.3.1. No substantive study information is changed.
    Difference
    0.0%
    Check dated 2025-12-01T17:59:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Clinical Trial page.